This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Myostin Therapeutics Pty Ltd. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Craig Desmond McFarlane: Innovator in Muscle Strength Enhancement
Introduction
Craig Desmond McFarlane is a notable inventor based in Hamilton, New Zealand. He has made significant contributions to the field of muscle strength enhancement through his innovative research and development. His work focuses on isolated polypeptides that have the potential to improve muscle strength.
Latest Patents
McFarlane holds a patent for "Isolated polypeptides and methods of improving muscle strength." This patent describes an isolated recombinant polypeptide that exhibits myostatin antagonist activity. The invention includes a C-terminally truncated mature myostatin peptide, with truncation occurring at a position between amino acids 281 and 329, or a fragment, variant, or derivative thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, McFarlane has been associated with Myostin Therapeutics Pty Ltd, where he has been instrumental in advancing research related to muscle strength. His expertise in the field has positioned him as a key figure in the development of therapeutic solutions aimed at enhancing muscle performance.
Collaborations
McFarlane has collaborated with notable colleagues, including Gina Diane Nicholas and Carole J Berry. These partnerships have contributed to the advancement of research and innovation in the field of muscle strength enhancement.
Conclusion
Craig Desmond McFarlane is a pioneering inventor whose work in isolated polypeptides has the potential to revolutionize muscle strength enhancement. His contributions to the field are significant and continue to inspire further research and development.